Institutional Fund
Act Capital Management, LLC
Wayne, PACIK 14422732 filings on record
Portfolio Value
$127.23M
Q1 2026
Holdings
56
Reported positions
New Buys
20
Opened this quarter
QoQ Change
+2.9%
from $123.67M
Portfolio Value Trend
Reported 13F value by quarter
Portfolio value trend — upgrade to see history
UpgradeTop Allocations
Largest positions by weight
- Krystal Biotech Inc12.3%
- Chevron Corp New12.2%
- Exxon Mobil Corp9.3%
- Celcuity Inc8.2%
- Tg Therapeutics Inc6.5%
- Abivax SA6.2%
- Other45.3%
Portfolio Holdings
56 positions · Q1 2026
| # | Security | Shares | Value | % Port. | Δ Shares | Activity |
|---|---|---|---|---|---|---|
| 1 | Krystal Biotech Inc | 60.5K | $15.62M | 12.3% | −23 | Reduced |
| 2 | Chevron Corp New | 75.0K | $15.52M | 12.2% | −3.5K | Reduced |
| 3 | Exxon Mobil Corp | 70.0K | $11.88M | 9.3% | −12.5K | Reduced |
| 4 | Celcuity Inc | 91.7K | $10.46M | 8.2% | +28.3K | Added |
| 5 | Tg Therapeutics Inc | 249.0K | $8.27M | 6.5% | −19.9K | Reduced |
| 6 | Abivax SA | 70.9K | $7.89M | 6.2% | +7.0K | Added |
| 7 | Amazon Com Inc | 33.0K | $6.87M | 5.4% | +8.4K | Added |
| 8 | Viking Therapeutics Inc | 209.3K | $6.81M | 5.4% | +3.2K | Added |
| 9 | Arrowhead Pharmaceuticals In | 82.5K | $5.17M | 4.1% | +7.5K | Added |
| 10 | Nektar Therapeutics | 70.9K | $5.10M | 4.0% | +19.7K | Added |
46 more holdings on Premium
See this fund's complete portfolio, full position changes, and activity history.
Unlock full portfolio